HIV Diagnostics Market forecast to grow at 9.5% CAGR up to 2023: Fractovia.org
The report “HIV Diagnostics Market Size By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023”, HIV Diagnostics Market size is projected to reach CAGR of 9.5% during the forecast period and was $2400 million in 2015. Due to technological innovations in disease diagnostic tests and rapid development of CD4, EID and P24 tests, the global industry is predicted to record an enhanced growth during forecast period. Simple amplification based assay - a blood diagnostic kit created by Cambridge university scientists received the “Popular Prize “at European Inventor award ceremony held on June 9, 2016 by European patent office. This kit can identify ailments like hepatitis B and HIV within less than 90 minutes by taking blood sample of the patient. The test cost only $17 and is same as pregnancy test where one stripe is positive and second is negative. This kit was used to test 40,000 persons for HIV in rural Africa. According to Helen Lee, who headed the team of Cambridge university researchers to develop the device, said that just a single drop of blood sample helps in detecting and treating the ailments in rural areas.
Thailand has become the first Asian nation to eradicate mother to child HIV transmission as per WHO reports achieving a greater milestone in its fight against the dreaded disease. Describing the eradication as an outstanding achievement, WHO said that Thailand was the first nation with large HIV endemic to assure an AIDS free population. This pronouncement is a boost for Thai health workers who have changed the country from one of the Asia’s most HIV ravaged communities to pin up the problem of efficiently handling the disease. According to WHO, routine screening tests conducted for HIV infected pregnant women along with free medication facilities in the country played a key role in preventing transmission of HIV virus from mother to child. The global HIV diagnostics market is segmented into key geographical regions including North America, Asia Pacific, Latin America, Europe and MEA. North America accounted for biggest revenue share of global HIV diagnostics market for 2015 contributing about $946 million to the total revenue. The factors attributed to 1|Page
the growth of the industry were presence of technologically modernized healthcare support, favourable compensation policies and comparatively high spending on healthcare research activities. The region is predicted to experience enhanced industry demand during the forecast period owing to technological development of portable diagnostic tests. Asia Pacific HIV diagnostics market is predicted to grow rapidly during forecast period owing to heavy industry demand from countries like China and India and a large percentage of population affected by HIV. It is projected to register a CAGR of 10.7% due to improved healthcare services and growing levels of consciousness about the disease amongst the population of the region.
U.S. HIV Diagnostics Market Size, by Product, 2012 - 2023 (USD Million)
2|Page
Key Industry Players of HIV Diagnostics Market:
Abbott Healthcare BD Biosciences Roche Diagnostics Zyomyx Incorporation Merck & Company Incorporation Bristol-Myers Squibb Janssen Therapeutics Hologic Incorporation Chembio Diagnostic Systems Alere Incorporation Sysmex Incorporation bioMerieux Abbvie Incorporation Gilead Sciences Qiagen VIIV Healthcare Beckman Coulter Apogee Flow Systems Limited Partec PointCare Technologies Incorporation Mylan Incorporation Siemens Healthcare Cepheid Daktari Diagnostics
3|Page
Segmentation of HIV Diagnostics Market:
Global Market Insights has segmented the HIV diagnostics Industry on the basis of product, and region: Global HIV Diagnostics Product Market Analysis (Revenue, USD Million; 2012 2023)
Antibody Tests o HIV-1 Screening ELISA/EIA Home Access Dried Blood Spot Rapid Test o HIV-1 Confirmatory Steps Western Blot Test Indirect Immunoflorescent Antibody Assay (IIFA) Line Immunoassay RadioImmunoPrecipitation Assay (RIPA) o HIV-2 & Group O Test Blood Antibody Dried Blood Spot Line Immunoassay o Viral Identification Assay P24 Antigen Qualitative PCR Test Viral Culture o CD4 Test o Viral Load Test o Early Infant Diagnosis
HIV Diagnostics Market Regional Analysis (Revenue, USD Million, 2012 – 2023)
North America o U.S. o Canada Europe o Germany o UK Asia Pacific o China o Japan LATAM o Brazil
4|Page

MEA o
South Africa
About Fractovia.org Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributers.
Contact Us:
Fractovia 29L Atlantic Avenue, Suite L 105, Ocean View, Delaware 19970 United States Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@fractovia.org Website: https://www.fractovia.org
5|Page